To compare the tumor targeting and clearance profiles of P-cadherin LP-DART and its scDb without Fc component, we evaluated whole-body biodistribution of P-cadherin DART-VT680 in HCT116 xenograft model (Supplementary Figure 2B and 2C). The gene discussed is CDH3; the disease is neoplasm.